Pfizer sues Metsera, Novo Nordisk
Digest more
Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...
Novo Nordisk cuts over 800 jobs in Plainsboro, part of a global restructuring under the new CEO, reflecting a troubling trend ...
The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...
A chart showing Novo Nordisk’s projected sales in an article on Thursday included its diabetes medicine Rybelsus as well as its obesity drugs ...
Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.
Novo Nordisk layoffs: Denmark-based pharmaceuticals major, Novo Nordisk's Chief Executive Officer (CEO) Mike Doustdar, on ...
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s unsolicited proposal to acquire Metsera, renewed legal action against Tylenol’s manufacturer following statements from Robert F.
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback